AAAAAA

   
Results: 1-25 | 26-41
Results: 1-25/41
RECENT ADVANCES IN THE PHARMACOTHERAPY OF SCHIZOPHRENIA
Authors: BORISON RL
Citation: Rl. Borison, RECENT ADVANCES IN THE PHARMACOTHERAPY OF SCHIZOPHRENIA, Harvard review of psychiatry, 4(5), 1997, pp. 255-271
ESTROGEN REPLACEMENT AND RESPONSE TO FLUOXETINE IN A MULTICENTER GERIATRIC DEPRESSION TRIAL
Authors: SCHNEIDER LS SMALL GW HAMILTON SH BYSTRITSKY A NEMEROFF CB MEYERS BS ABUZZAHAB FS ALEXOPOULOS GS BIELSKI RJ BORISON RL BROD MS COHENCOLE SA COHN CK DOWNS JM DUPONT RL FERGUSON JM FOLKS DG GOTTLIEB GL GRABER B MENOLASCINO FJ HALARIS AE HARTFORD JT HERTZMAN M JEFFERSON JW JESTE DV KORAN LM LAZARUS LW NAKRA BRS OXENKRUG GF RAPPAPORT SA ROSENTHAL MH SALZMAN C SHRIVASTAVA R STOKES PE WINSTON JL WHEADON DW SCHATZ EJ MARVEL DE ALBRITTON R TOLLEFSON GD
Citation: Ls. Schneider et al., ESTROGEN REPLACEMENT AND RESPONSE TO FLUOXETINE IN A MULTICENTER GERIATRIC DEPRESSION TRIAL, The American journal of geriatric psychiatry, 5(2), 1997, pp. 97-106
MULTIPLE FIXED DOSES OF SEROQUEL (QUETIAPINE) IN PATIENTS WITH ACUTE EXACERBATION OF SCHIZOPHRENIA - A COMPARISON WITH HALOPERIDOL AND PLACEBO
Authors: ARVANITIS LA MILLER BG BORISON RL PITTS WM SHARIF ZA HAMNER MB HERZ MI TRUE JE VELLIGAN D KNESEVICH MA SMALL J STEINBOOK R HERTZMAN M KECK PE NEWCOMER JW GRACE J ROTROSEN J TANDON R DOTT SG FERGUSON JM ADDINGTON DEN MACEWAN GW NAIR VNP SHRIQUI CL WILLIAMS R DANIEL DG SHEHI GM PATTERSON WM MERIDETH CH
Citation: La. Arvanitis et al., MULTIPLE FIXED DOSES OF SEROQUEL (QUETIAPINE) IN PATIENTS WITH ACUTE EXACERBATION OF SCHIZOPHRENIA - A COMPARISON WITH HALOPERIDOL AND PLACEBO, Biological psychiatry, 42(4), 1997, pp. 233-246
A RANDOMIZED, CONTROLLED, DOSE-RANGING TRIAL OF SERTINDOLE IN PATIENTS WITH SCHIZOPHRENIA
Authors: VANKAMMEN DP MCEVOY JP TARGUM SD KARDATZKE D SEBREE TB ANDORN A BAKER RW SCHOOLER NR BORISON RL CASEY D ERESHEFSKY L FUNDERBERG L HAMNER M KARSON C MARDER S MCKINNEY W SMALL JG TAMMINGA C TUASON V VOLAVKA J CHUNG L
Citation: Dp. Vankammen et al., A RANDOMIZED, CONTROLLED, DOSE-RANGING TRIAL OF SERTINDOLE IN PATIENTS WITH SCHIZOPHRENIA, Psychopharmacology, 124(1-2), 1996, pp. 168-175
THE EFFICACY AND SAFETY OF DONEPEZIL IN PATIENTS WITH ALZHEIMERS-DISEASE - RESULTS OF A US MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: ROGERS SL FRIEDHOFF LT APTER JT RICHTER RW HARTFORD JT WALSHE TM BAUMEL B LINDEN RD KINNEY FC DOODY RS BORISON RL AHEM GL
Citation: Sl. Rogers et al., THE EFFICACY AND SAFETY OF DONEPEZIL IN PATIENTS WITH ALZHEIMERS-DISEASE - RESULTS OF A US MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Dementia, 7(6), 1996, pp. 293-303
A COMPARISON OF 5 FIXED DOSES OF SEROQUEL (ICI-204,636) WITH HALOPERIDOL AND PLACEBO IN PATIENTS WITH SCHIZOPHRENIA
Authors: BORISON RL ARVANITIS LA MILLER BG
Citation: Rl. Borison et al., A COMPARISON OF 5 FIXED DOSES OF SEROQUEL (ICI-204,636) WITH HALOPERIDOL AND PLACEBO IN PATIENTS WITH SCHIZOPHRENIA, Schizophrenia research, 18(2-3), 1996, pp. 1-1
OLANZAPINE VERSUS PLACEBO AND HALOPERIDOL - ACUTE-PHASE RESULTS OF THE NORTH-AMERICAN DOUBLE-BLIND OLANZAPINE TRIAL
Authors: BEASLEY CM TOLLEFSON G TRAN P SATTERLEE W SANGER T HAMILTON S FABRE L SMALL J ERESHEFSKY L TRUE J NEMEROFF C RISCH SC PERRY PJ POTKIN SG BORISON RL JAMES S MELTZER HY IQBAL N FANN WE GEWIRTZ GR LANDBLOOM R ROYBYRNE PP TUASON VB CARMAN JS STOKES PE WILLIAMS R ANCILL RJ MACEWAN GW GUJAVARTY KS JONES B LOHR JB
Citation: Cm. Beasley et al., OLANZAPINE VERSUS PLACEBO AND HALOPERIDOL - ACUTE-PHASE RESULTS OF THE NORTH-AMERICAN DOUBLE-BLIND OLANZAPINE TRIAL, Neuropsychopharmacology, 14(2), 1996, pp. 111-123
ICI-204,636, AN ATYPICAL ANTIPSYCHOTIC - EFFICACY AND SAFETY IN A MULTICENTER, PLACEBO-CONTROLLED TRIAL IN PATIENTS WITH SCHIZOPHRENIA
Authors: BORISON RL ARVANITIS LA MILLER BG ALPHS LD CARMAN JS DIAMOND B GEWIRTZ G HAMNER MB HIRSHFIELD R MCEVOY JP MUKHERJEE S NASRALLAH HA OXENKRUG G RYAN W SMITH N TAMMINGA C
Citation: Rl. Borison et al., ICI-204,636, AN ATYPICAL ANTIPSYCHOTIC - EFFICACY AND SAFETY IN A MULTICENTER, PLACEBO-CONTROLLED TRIAL IN PATIENTS WITH SCHIZOPHRENIA, Journal of clinical psychopharmacology, 16(2), 1996, pp. 158-169
CHANGING ANTIPSYCHOTIC MEDICATION - GUIDELINES ON THE TRANSITION TO TREATMENT WITH RISPERIDONE
Authors: BORISON RL
Citation: Rl. Borison, CHANGING ANTIPSYCHOTIC MEDICATION - GUIDELINES ON THE TRANSITION TO TREATMENT WITH RISPERIDONE, Clinical therapeutics, 18(4), 1996, pp. 592-607
EFFICACY OF 4 MG DAY AND 8 MG/DAY ILOPERIDONE (HP-873) ADMINISTERED TO SCHIZOPHRENIC-PATIENTS FOR 42 DAYS/
Authors: BORISON RL HUFF FJ GRIFFITHS L RAMASWAMY R SHIPLEY JE
Citation: Rl. Borison et al., EFFICACY OF 4 MG DAY AND 8 MG/DAY ILOPERIDONE (HP-873) ADMINISTERED TO SCHIZOPHRENIC-PATIENTS FOR 42 DAYS/, Psychopharmacology bulletin, 32(3), 1996, pp. 416-416
LONG-TERM TACRINE (COGNEX) TREATMENT - EFFECTS ON NURSING-HOME PLACEMENT AND MORTALITY
Authors: KNOPMAN D SCHNEIDER L DAVIS K TALWALKER S SMITH F HOOVER T GRACON S APTER JT BARNETT M BAUMEL B EISNER LS BENNETT D FORCHETTI C BLASS JP BORISON RL CELESIA GG DEXTER J DOODY R DUBOFF EA EARL NL FARLOW M HENDRIE HC FARMER M FERGUSON J FOSTER NL GREENWALD M GROENENDYK A JURKOWSKI C KATZ I PRODNER CK KNOPMAN DS MARGOLIN RA MORRIS JC RUBIN EH REYES PF RYMER MM SADOWSKY CH PAWLUCZYK S SMITH WT SOLOMON PR PENDLEBURY WW TAYLOR J THEIN SG TUTTLE P TYNDALL RJ
Citation: D. Knopman et al., LONG-TERM TACRINE (COGNEX) TREATMENT - EFFECTS ON NURSING-HOME PLACEMENT AND MORTALITY, Neurology, 47(1), 1996, pp. 166-177
A MULTIPLE FIXED-DOSE, PLACEBO-CONTROLLED TRIAL WITH SEROQUEL - AN ATYPICAL ANTIPSYCHOTIC
Authors: BORISON RL ARVANITIS LA MILLER BG
Citation: Rl. Borison et al., A MULTIPLE FIXED-DOSE, PLACEBO-CONTROLLED TRIAL WITH SEROQUEL - AN ATYPICAL ANTIPSYCHOTIC, Biological psychiatry, 39(7), 1996, pp. 333-333
IMPACT OF PHYSICAL ILLNESS ON QUALITY-OF-LIFE AND ANTIDEPRESSANT RESPONSE IN GERIATRIC MAJOR DEPRESSION
Authors: SMALL GW BIRKETT M MEYERS BS KORAN LM BYSTRITSKY A NEMEROFF CB ABUZZAHAB FS ALEXOPOULOS GS BIELSKI RJ BORISON RL BROD MS COHENCOLE SA COHN CK DOWNS JM DUPONT RL FERGUSON JM FOLKS DG GOTTLIEB GL GRABER B MENOLASCINO FJ HALARIS AE HARTFORD JT HERTZMAN M JEFFERSON JW JESTE DV LAZARUS LW NAKRA BR OXENKRUG GF RAPPAPORT SA ROSENTHAL MH SALZMAN C SHRIVASTAVA RK STOKES PE WINSTON JL WHEADON DW SCHATZ EJ MARVEL DE ALBRITTON R TOLLEFSON GD LILLY E
Citation: Gw. Small et al., IMPACT OF PHYSICAL ILLNESS ON QUALITY-OF-LIFE AND ANTIDEPRESSANT RESPONSE IN GERIATRIC MAJOR DEPRESSION, Journal of the American Geriatrics Society, 44(10), 1996, pp. 1220-1225
THE ROLE OF COGNITION IN THE RISK-BENEFIT AND SAFETY ANALYSIS OF ANTIPSYCHOTIC MEDICATION
Authors: BORISON RL
Citation: Rl. Borison, THE ROLE OF COGNITION IN THE RISK-BENEFIT AND SAFETY ANALYSIS OF ANTIPSYCHOTIC MEDICATION, Acta psychiatrica Scandinavica, 94, 1996, pp. 5-11
NEW DRUGS FOR FRAGILE PATIENTS - TREATMENT OF PSYCHOSES IN THE ELDERLY
Authors: BORISON RL
Citation: Rl. Borison, NEW DRUGS FOR FRAGILE PATIENTS - TREATMENT OF PSYCHOSES IN THE ELDERLY, The American journal of geriatric psychiatry, 3(3), 1995, pp. 247-247
A PATH-ANALYTICAL APPROACH TO DIFFERENTIATE BETWEEN DIRECT AND INDIRECT DRUG EFFECTS ON NEGATIVE SYMPTOMS IN SCHIZOPHRENIC-PATIENTS - A REEVALUATION OF THE NORTH-AMERICAN RISPERIDONE STUDY
Authors: MOLLER HJ MULLER H BORISON RL SCHOOLER NR CHOUINARD G
Citation: Hj. Moller et al., A PATH-ANALYTICAL APPROACH TO DIFFERENTIATE BETWEEN DIRECT AND INDIRECT DRUG EFFECTS ON NEGATIVE SYMPTOMS IN SCHIZOPHRENIC-PATIENTS - A REEVALUATION OF THE NORTH-AMERICAN RISPERIDONE STUDY, European archives of psychiatry and clinical neuroscience, 245(1), 1995, pp. 45-49
ABSENCE OF NEUROPSYCHOLOGICAL EFFECTS FOLLOWING SELECTIVE ALPHA(2) AGONIST TREATMENT IN CHRONIC-SCHIZOPHRENIA
Authors: LEE GP HAVERSTOCK SL REED MF BORISON RL DIAMOND BI
Citation: Gp. Lee et al., ABSENCE OF NEUROPSYCHOLOGICAL EFFECTS FOLLOWING SELECTIVE ALPHA(2) AGONIST TREATMENT IN CHRONIC-SCHIZOPHRENIA, Schizophrenia research, 15(1-2), 1995, pp. 125-125
EFFECTS OF NOREPINEPHRINE MODULATION BY GUANABENZ IN SCHIZOPHRENIA
Authors: HAVERSTOCK SL LEE GP BORISON RL DIAMOND BI
Citation: Sl. Haverstock et al., EFFECTS OF NOREPINEPHRINE MODULATION BY GUANABENZ IN SCHIZOPHRENIA, Schizophrenia research, 15(1-2), 1995, pp. 152-152
RELATIONSHIP BETWEEN CREATINE-PHOSPHOKINASE, PSYCHOTIC SYMPTOMS AND NOVEL ANTIPSYCHOTIC-DRUGS
Authors: PATHIRAJA AP DIAMOND BI BORISON RL MEIBECH RC ANAND R
Citation: Ap. Pathiraja et al., RELATIONSHIP BETWEEN CREATINE-PHOSPHOKINASE, PSYCHOTIC SYMPTOMS AND NOVEL ANTIPSYCHOTIC-DRUGS, Schizophrenia research, 15(1-2), 1995, pp. 160-161
PHENOMENOLOGY AND NEUROBIOLOGY OF COCAINE WITHDRAWAL - ARE THEY RELATED
Authors: PATHIRAJA A MARAZZITI D CASSANO GB DIAMOND BI BORISON RL
Citation: A. Pathiraja et al., PHENOMENOLOGY AND NEUROBIOLOGY OF COCAINE WITHDRAWAL - ARE THEY RELATED, Progress in neuro-psychopharmacology & biological psychiatry, 19(6), 1995, pp. 1021-1034
UNEXPECTED DYSTONIA WHILE CHANGING FROM CLOZAPINE TO RISPERIDONE
Authors: RADFORD JM BROWN TM BORISON RL
Citation: Jm. Radford et al., UNEXPECTED DYSTONIA WHILE CHANGING FROM CLOZAPINE TO RISPERIDONE, Journal of clinical psychopharmacology, 15(3), 1995, pp. 225-226
CLINICAL EFFICACY OF SEROTONIN-DOPAMINE ANTAGONISTS RELATIVE TO CLASSIC NEUROLEPTICS
Authors: BORISON RL
Citation: Rl. Borison, CLINICAL EFFICACY OF SEROTONIN-DOPAMINE ANTAGONISTS RELATIVE TO CLASSIC NEUROLEPTICS, Journal of clinical psychopharmacology, 15(1), 1995, pp. 24-29
NEW ANTIPSYCHOTIC TREATMENTS FOR SCHIZOPHRENIA - INTRODUCTION
Authors: BORISON RL
Citation: Rl. Borison, NEW ANTIPSYCHOTIC TREATMENTS FOR SCHIZOPHRENIA - INTRODUCTION, Psychiatric annals, 25(5), 1995, pp. 283-284
NEW ANTIPSYCHOTICS TREATMENTS FOR SCHIZOPHRENIA - PANEL DISCUSSION - QUESTIONS FROM THE AUDIENCE
Authors: BORISON RL ROTROSEN J ERESHEFSKY L MCEVOY JP",SCHOOLER,"OPLER LA
Citation: Rl. Borison et al., NEW ANTIPSYCHOTICS TREATMENTS FOR SCHIZOPHRENIA - PANEL DISCUSSION - QUESTIONS FROM THE AUDIENCE, Psychiatric annals, 25(5), 1995, pp. 311-313
PAROXETINE TREATMENT OF ANGER ASSOCIATED WITH DEPRESSION
Authors: ALBRITTON J BORISON RL
Citation: J. Albritton et Rl. Borison, PAROXETINE TREATMENT OF ANGER ASSOCIATED WITH DEPRESSION, The Journal of nervous and mental disease, 183(10), 1995, pp. 666-667
Risultati: 1-25 | 26-41